News
Multidisciplinary CMCO Making Strides
The term “basic” is used to describe scientific discoveries made on a fundamental level. They are essential to translational work by scientists and physician-scientists, who bridge cancer biology with clinical investigation, specifically to bring better treatments and diagnostic tools to patients.
It’s been an exciting year for basic science research at the Center for Molecular and Cellular Oncology (CMCO), says its inaugural director Markus Müschen, MD, PhD, Arthur H. and Isabel Bunker Professor of Hematology at Yale School of Medicine.